Rosemarie Plaetke
University of Utah
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rosemarie Plaetke.
Psychiatry Research-neuroimaging | 1991
Merilyne Waldo; Gregory Carey; Marina Myles-Worsley; Ellen Cawthra; Lawrence E. Adler; Herbert T. Nagamoto; Paul H. Wender; William Byerley; Rosemarie Plaetke; Robert Freedman
Because the clinical diagnosis of schizophrenia has not generally been an adequate phenotypic marker to detect the genes that convey risk for schizophrenia, efforts have been directed toward the identification of more elementary neuronal dysfunctions in schizophrenic patients and their families. Psychophysiological studies of sensory gating and selective attention suggest that defects in these brain functions are present in schizophrenic patients and some of their relatives. This study examines one of these defects in sensory gating, failure to suppress the P50 evoked response to repeated auditory stimuli. Six pedigrees, chosen because of the presence of large sibships containing several cases of schizophrenia, were studied. A mathematical model was developed to assess the familial association of the P50 defect with schizophrenia. The model preserves the quantitative nature of the data and is suitable for use in a sample with small numbers of pedigrees comprising many individuals. It is thus suitable for the evaluation of putative phenotypes in families to be studied by linkage analysis with polymorphic genetic markers. The results suggest that the P50 defect is familially associated with schizophrenia.
Genomics | 1989
Roger K. Wolff; Rosemarie Plaetke; Alec J. Jeffreys; Ray White
To investigate the hypothesis that unequal exchange between homologous chromosomes is involved when new alleles are generated at VNTR loci, we used genetic linkage maps to identify flanking markers surrounding a VNTR marker locus. The minisatellite probe lambda MS1 was selected, as the hypervariable locus it detects undergoes spontaneous generation of new alleles in the germline at a rate of approximately 5%. Multipoint linkage analysis placed lambda MS1 within a cluster of polymorphic marker loci on chromosome 1p. Using the two closest flanking markers, CMM8 and YNZ2, we were able to characterize 12 new-allele events in terms of crossingover between the flanking markers. Statistical analysis of these data has allowed us to reject the model that assumes that events generating new alleles always involve unequal exchange between homologous chromosomes at meiosis.
Biological Psychiatry | 1993
Hilary Coon; Rosemarie Plaetke; John Holik; M. Hoff; Marina Myles-Worsley; Marilyne Waldo; Robert Freedman; William Byerley
Traditional diagnostic techniques may not provide all the information necessary to reveal the genetic causes of schizophrenia through linkage analysis. Use of neurophysiological indicator variables that are associated with the disease may increase the probability of detecting linkage. Such variables not only produce simpler phenotypes for analysis, but they also may be more proximal to the gene products involved in neurological dysfunctions underlying schizophrenia. We have used a previously characterized neurophysiological variable, the P50 evoked-auditory response, to search for chromosomal regions that may be of interest in the study of schizophrenia. Although our scan of over 300 markers did not show strong evidence for linkage to P50 in nine families, this exploratory analysis has revealed several chromosomal regions that may deserve further study.
Human Heredity | 1992
William Byerley; Rosemarie Plaetke; M. Hoff; S. Jensen; John Holik; Fred W. Reimherr; Charles David Mellon; Paul H. Wender; P. O'Connell; M. Leppert
We ascertained 8 multigenerational pedigrees afflicted with multiple cases of bipolar and recurrent major depressive disorder. Alterations in dopaminergic and noradrenergic neurotransmission have been implicated in the pathogenesis of this disease, and tyrosine hydroxylase (TH) is the rate-limiting enzyme in the synthesis of these two catecholamines. As TH mutations could underlie susceptibility to manic-depression, we carried out a linkage analysis between this disease in 8 families and two RFLP probes that map to the TH gene region on the short arm of chromosome 11. Evidence of linkage was not found in 7 of 8 kindreds.
Arteriosclerosis, Thrombosis, and Vascular Biology | 1991
Mitsuru Emi; Robert M. Hegele; Paul N. Hopkins; Lily L. Wu; Rosemarie Plaetke; Roger R. Williams; Jean Marc Lalouel
In the course of familial investigations of coronary artery disease, we identified an extended kinship in which several members were affected with type IIa hyperlipoproteinemia (HLPIIa), type III dyslipoproteinemia (DLPIII), or hypobetalipoproteinemia (HBLP). To study the genetic defects responsible for plasma lipoprotein abnormalities in this pedigree and to investigate the phenotypic effect of different genotypic combinations, we used molecular markers for apolipoprotein (apo) B, apo E, and the low density lipoprotein (LDL) receptor to characterize segregation at each locus. Linkage analysis showed that elevated LDL cholesterol levels and the HBLP phenotype were due to defects at the LDL receptor and the apo B loci, respectively. One pedigree member, who inherited both an LDL receptor allele linked with elevated LDL cholesterol levels and an apo B allele linked with HBLP, had a normal lipoprotein phenotype. Seven patients who simultaneously inherited the defective LDL receptor allele and one or two apo E2 alleles manifested DLPIII. The E2 alleles in this pedigree were shown by DNA sequence analysis to be the common E2 158 (arginine----cysteine) allele. These findings suggested a possible interaction between the abnormal LDL receptor and apo E2 alleles, resulting in the expression of DLPIII in the presence of a single copy of ago E2.
Human Heredity | 1992
S. Jensen; Rosemarie Plaetke; John Holik; M. Hoff; P. O'connell; F. Reimherr; Paul H. Wender; Q. Y. Zhou; Olivier Civelli; M. Litt; M. Leppert; William Byerley
Disturbances in dopaminergic activity may play an important role in the pathogenesis of manic depression. The effects of dopamine are mediated by at least five G protein coupled receptors, D1, D2, D3, D4 and D5. Recently, three separate research groups have cloned and characterized the D1 dopamine receptor, which localizes to 5q35.1. We undertook a linkage analysis between the D1 receptor polymorphisms and manic depression in six families in which segregation of the disease was consistent with autosomal dominant inheritance. A highly polymorphic flanking DNA marker, CRI-L1200, was also analyzed as the D1 gene RFLPs were relatively uninformative in our families. Multipoint analyses of manic depression and these DNA markers resulted in lod scores of less than -3.0 at the D1 locus, indicating that the D1 dopamine receptor gene does not confer an inherited susceptibility to manic-depressive illness in the families studied.
Human Heredity | 1993
Steven Jensen; Rosemarie Plaetke; John Holik; M. Hoff; Marina Myles-Worsley; M. Leppert; Hilary Coon; Kevin Vest; Robert Freedman; M. Waldo; Qun-Yong Zhou; Mike Litt; Olivier Civelli; William Byerley
Alterations in dopaminergic activity may play an important role in the pathogenesis of schizophrenia. The central effects of dopamine are mediated by at least five G protein-coupled receptors, D1, D2, D3, D4 and D5. The D1 receptor maps to 5q35.1 and it identifies an Eco RI as well as a Taq I RFLP. In the present study we undertook a linkage analysis between the D1 receptor RFLPs and schizophrenia in 9 multigenerational families in which segregation of disease was consistent with autosomal dominant inheritance and reduced penetrance. Several flanking DNA markers were also analyzed as the D1 receptor RFLPs were relatively uninformative in our families. Pairwise analyses of schizophrenia and several flanking markers indicate that inheritability of this region is unlikely to be involved in the pathogenesis of schizophrenia in the 9 families studied.
American Journal of Human Genetics | 1993
Hilary Coon; William Byerley; John Holik; M. Hoff; Marina Myles-Worsley; Lars Lannfelt; Pierre Sokoloff; Jean Schwartz; Merilyne Waldo; Robert Freedman; Rosemarie Plaetke
American Journal of Human Genetics | 1993
Hilary Coon; S. Jensen; M. Hoff; John Holik; Rosemarie Plaetke; Fred W. Reimherr; Paul H. Wender; M. Leppert; William Byerley
Genomics | 1989
S.J. Odelberg; Rosemarie Plaetke; J.R. Eldridge; L. Ballard; P. O'Connell; Yusuke Nakamura; M. Leppert; Jean-Marc Lalouel; Ray White